Cambridge Cognition Holdings Plc (AIM:COG)

Market Cap	15.61M
Revenue (ttm)	10.34M
Net Income (ttm)	-1.79M
Shares Out	41.64M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	53.57
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,113
Average Volume	18,827
Open	36.50
Previous Close	37.50
Day's Range	36.50 - 39.00
52-Week Range	26.40 - 49.00
Beta	0.62
RSI	54.30
Earnings Date	May 2, 2025

About AIM:COG

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval. It also offers eCOA, a data management tool for clinical scales which supports questionnaires and issue resolutions; and provides ...

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 2012
• Employees: 119
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: COG

Financial Performance

In 2024, AIM:COG's revenue was 10.34 million, a decrease of -23.48% compared to the previous year's 13.52 million. Losses were -1.79 million, -49.12% less than in 2023.